Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence

Rituximab is a first-line treatment for membranous nephropathy. Nephrotic syndrome limits rituximab exposure due to urinary drug loss. Rituximab underdosing (serum level

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Kidney international reports 2024-01, Vol.9 (1), p.134-144
Hauptverfasser:	Destere, Alexandre, Teisseyre, Maxime, Merino, Diane, Cremoni, Marion, Gérard, Alexandre O, Crepin, Thomas, Jourde-Chiche, Noémie, Graça, Daisy, Zorzi, Kévin, Fernandez, Céline, Brglez, Vesna, Benzaken, Sylvia, Esnault, Vincent L M, Benito, Sylvain, Drici, Milou-Daniel, Seitz-Polski, Barbara
Format:	Artikel
Sprache:	eng
Schlagworte:	Artificial Intelligence Clinical Research Computer Science Human health and pathology Immunology Immunotherapy Life Sciences Urology and Nephrology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Rituximab is a first-line treatment for membranous nephropathy. Nephrotic syndrome limits rituximab exposure due to urinary drug loss. Rituximab underdosing (serum level
ISSN:	2468-0249 2468-0249
DOI:	10.1016/j.ekir.2023.10.023